Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Publication year range
1.
Bull Exp Biol Med ; 139(1): 46-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-16142273

ABSTRACT

The system of energy supply in the myocardium of the left and right ventricles did not recover after short-term circulatory disturbances. ATP synthesis decreased in parallel with activation of poly-(ADP-ribose)-polymerase in the ischemic region of the right ventricle, extra-ischemic region, and in the left ventricle by 5.85, 5.4, and 2.2 times, respectively. Intravenous injection of NAD immediately after blood flow resumption in the subacute period of ischemia-reperfusion damage virtually completely normalized the pool of adenine nucleotides, energy change of the adenine nucleotide system, and phosphorylation potential. Exogenous NAD inhibited activity of poly-(ADP-ribose)-polymerase in the ischemic region of the right ventricle, extra-ischemic region, and in the ischemic region of the left ventricle by 2.4, 2.9, and 1.52 times, respectively. We hypothesize that NAD acts as a regulator of signal mechanism of apoptosis induction during ischemia-reperfusion damages to the myocardium.


Subject(s)
Adenine Nucleotides/metabolism , Apoptosis , Myocardial Reperfusion Injury/metabolism , Myocardium/metabolism , NAD/pharmacology , Adenosine Triphosphate/metabolism , Animals , Dogs , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/pathology , Myocardial Reperfusion Injury/pathology , Myocardium/pathology , NAD/physiology , Phosphocreatine/metabolism , Phosphorylation , Poly(ADP-ribose) Polymerase Inhibitors , Poly(ADP-ribose) Polymerases/metabolism
2.
Patol Fiziol Eksp Ter ; (3): 3-8, 1999.
Article in Russian | MEDLINE | ID: mdl-10498985

ABSTRACT

It is shown that cardiotropic drug refracterin promotes recovery of cardiac contraction and relaxation, their coordination destroyed in cardiac failure (CF) caused by 10-day toxico-allergic myocarditis (TAM). Pumping capacity of the heart returns to normal after normalization of functional activity of three systems of cardiomyocyte responsible for contraction-relaxation: contractile proteins, energy supply and calcium transport. The key process is refracterin-related reestablishment of normal content and proportion of adenyl nucleotides and creatininephosphate and regulation role of phosphorylation and energy of metabolic processes in the cells and their interaction. Thus, refracterin effectiveness lies in its ability to interfere in intracellular metabolic processes in the myocardium, to reestablish normal homeostasis of the systems responsible for contraction-relaxation function and eventually to remove left ventricular cardiac dysfunction.


Subject(s)
Acetyldigoxins/pharmacology , Cardiovascular Agents/pharmacology , Cytochrome c Group/pharmacology , Heart Failure/physiopathology , Heart/drug effects , Myocardial Contraction/drug effects , Myocarditis/physiopathology , Myocardium/ultrastructure , Oxyfedrine/pharmacology , Acetyldigoxins/therapeutic use , Animals , Biological Transport/drug effects , Calcium/metabolism , Cardiovascular Agents/therapeutic use , Cytochrome c Group/therapeutic use , Drug Combinations , Drug Evaluation, Preclinical , Heart/physiopathology , Heart Failure/drug therapy , Heart Failure/etiology , Hemodynamics/drug effects , Muscle Proteins/drug effects , Muscle Proteins/physiology , Myocardial Contraction/physiology , Myocarditis/complications , Myocarditis/drug therapy , Myocardium/metabolism , Oxyfedrine/therapeutic use , Rabbits , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL